ClinicalTrials.govpublic full text
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
chronic lymphocytic leukemia (cll), lymphoma, non-hodgkin (nhl), acute myeloid leukemia (aml), multiple myeloma (mm), cll, nhl, aml, mm, phosphatidylinositol 3-kinase, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835158
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.